Cardiology Trials cover art

All Episodes

Cardiology Trials — 142 episodes

#
Title
1

Special episode (ACC 2026: CHAMPION-AF, HI-PEITHO)

2

Summary and discussion of VICTORIA and VICTOR

3

Summary and discussion of DAPA-HF and EMPEROR-Reduced

4

Special episode (AHA 2025: OCEAN, ADAPT AF-DES)

5

Special episode (AHA 2025: VESALIUS-CV, DECAF)

6

Summary and discussion of PARADIGM-HF and PIONEER-HF

7

Special episode (ESC 2025: AQUATIC, VICTOR)

8

Special episode (ESC 2025: REBOOT-CNIC, BETAMI-DANBLOCK, DIGIT-HF)

9

Summary and discussion of BEST and SENIORS

10

Review of the A-HeFT trial

11

Review of the CHARM-Alternative trial

12

Summary and discussion of Carvedilol Prospective Randomized Cumulative Survival Study, Val-HeFT, CHARM-Added and CIBIS-II

13

Review of the CIBIS-II Trial

14

Review of the CHARM-Added trial

15

Review of the Val-HeFT trial

16

Review of the Carvedilol Prospective Randomized Cumulative Survival Study

17

Summary and discussion of U.S. Carvedilol Heart Failure, DIG, RALES, MERIT-HF, and ATLAS

18

Review of the ATLAS trial

19

Review of the MERIT-HF trial

20

Review of the RALES trial

21

Review of the DIG trial

22

Review of the U.S. Carvedilol Heart Failure Study

23

Summary and discussion of V-HEFT II and SOLVD

24

Review of the SOLVD trials

25

Review of the V-HEFT II trial

26

Summary and discussion of V-HEFT I and CONSENSUS

27

Review of the CONSENSUS trial

28

Review of the V-HEFT I Trial

29

Review of the CULPRIT-SHOCK Trial

30

Summary and discussion of MOSCA-FRAIL and SENIOR-RITA

31

Review of the SENIOR-RITA trial

32

Review of the MOSCA-FRAIL trial

33

Summary and discussion of TACTICS-TIMI 18, RITA 3 and ICTUS

34

Review of the ICTUS trial

35

Review of the RITA 3 trial

36

Review of the TACTICS-TIMI 18 trial

37

Summary and discussion of PRAMI, COMPLETE and FULL REVASC

38

Review of the FULL REVASC trial

39

Review of the COMPLETE trial

40

Review of the PRAMI Trial

41

Summary and discussion of TAPAS and TASTE

42

Summary and discussion of trials of fibrinolysis vs invasive strategy in STEMI

43

Review of the TASTE trial

44

Summary and discussion of OAT

45

Review of the TAPAS trial

46

Review of the STREAM trial

47

Summary and discussion of FAME and RIVAL

48

Review of the OAT Trial

49

Review of the DANAMI-2 trial

50

Review of the Primary Angioplasty in Myocardial Infarction Study Group trial

51

Review of the RIVAL trial

52

Review of the FAME trial

53

Summary and discussion of NORSTENT

54

Review of the NORSTENT trial

55

Our discussion of "Revisiting the PLATO trial"

56

Revisiting the PLATO trial

57

Summary and discussion of RAVEL, TAXUS-IV and SPIRIT IV

58

Review of the SPIRIT IV Trial

59

Review of the TAXUS-IV trial

60

Review of the RAVEL trial

61

Summary and discussion of FAME 3, BARI 2D and PREVENT

62

Review of the PREVENT trial

63

Summary and discussion of trials of PCI vs CABG

64

Review of the BARI 2D trial

65

Review of the FAME 3 trial

66

Review of the EXCEL trial

67

Review of the NOBLE Trial

68

Review of the FREEDOM trial

69

Review of the SYNTAX trial

70

Review of the ORBITA-2 trial

71

Summary and discussion of ISCHEMIA, ISCHEMIA-CKD, ORBITA and REVIVED-BCIS2

72

Review of the REVIVED-BCIS2 trial

73

Review of the ORBITA trial

74

Review of the ISCHEMIA and ISCHEMIA-CKD trials

75

Summary and discussion of RITA-2, atorvastatin vs angioplasty, COURAGE and FAME 2

76

Review of the FAME 2 Trial

77

Review of the COURAGE Trial

78

Review of the Atorvastatin versus Revascularization Treatment Investigators Trial

79

Review of the RITA-2 trial

80

Summary and discussion of STICH and ACME

81

Review of the ACME trial

82

Review of the STICH trial

83

Summary and discussion of trials of coronary artery bypass surgery in stable angina

84

Review of the Coronary Artery Bypass Graft Surgery Trialists Collaboration

85

Review of the Coronary Artery Surgery Study (CASS)

86

Review of the European Coronary Surgery Study

87

Review of the Veterans Administration Cooperative Study

88

A review of medical management after acute coronary syndrome

89

Summary and discussion of REDUCE-AMI

90

Review of the REDUCE-AMI trial

91

Summary and discussion of PARADISE-MI and EMPACT-MI

92

Review of the EMPACT-MI Trial

93

Review of the PARADISE-MI Trial

94

Summary and discussion of IMPROVE-IT, CANTOS, CIRT and COLCOT

95

Review of the COLCOT trial

96

Review of the CIRT trial

97

Review of the CANTOS Trial

98

Review of the IMPROVE-IT trial

99

Summary and discussion of ACCOAST and ISAR-REACT 5

100

Review of the ISAR-REACT 5 Trial

101

Review of the ACCOAST trial

102

Summary and discussion of TACT and ATLANTIC

103

Review of the ATLANTIC trial

104

Summary and discussion of NICE-SUGAR, TRITON-TIMI 38, TRILOGY ACS, PLATO and ATLAS ACS 2-TIMI 51

105

Review of the TACT Trial

106

Review of the ATLAS ACS 2-TIMI 51 trial

107

Review of the CURRENT-OASIS 7 trial

108

Review of the TRILOGY ACS trial

109

Review of the PLATO Trial

110

Review of the TRITON-TIMI 38 Trial

111

Review of the HORIZONS-AMI trial

112

Review of the OASIS-6 trial

113

Review of the OASIS-5 trial

114

Summary and discussion of CURE and DIGAMI 2

115

Review of DIGAMI 2

116

Review of the CURE Trial

117

Summary and discussion of MIRACL and PROVE IT-TIMI 22

118

Review of the PROVE IT-TIMI 22 Trial

119

Review of the MIRACL Trial

120

Summary and discussion of DIGAMI and FRISC

121

Review of the FRISC trial

122

Review of the DIGAMI trial

123

Summary and discussion of TRACE and EPHESUS

124

Review of the EPHESUS Trial

125

Review of the TRACE Study

126

Summary and discussion of CAPRICORN and COMMIT

127

Review of the COMMIT Trial

128

Review of the CAPRICORN Trial

129

Summary and discussion of SAVE and AIRE

130

Review of Acute Infarction Ramipril Efficacy (AIRE) Trial

131

Review of Survival and Ventricular Enlargement (SAVE) Trial

132

Summary and discussion of GISSI-3 and ISIS-4

133

Review of the ISIS-4 Trial

134

Review of the GISSI-3 Trial

135

Summary and discussion of CAST and ISIS-3

136

Review of the ISIS-3 Trial

137

Review of the Cardiac Arrhythmia Suppression Trial (CAST)

138

Summary and discussion of GISSI-1, 2 and ISIS-2

139

Review of the GISSI-2 Trial

140

Review of the ISIS-2 Trial

141

Review of the GISSI-1 Trial

142

BHAT and ISIS-I trials